ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,829Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 783

$1.07M Total Retail Price of All Prescriptions

Rank: 41 out of 783

840 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 840 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 840 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 15,970 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 717 651 1 7
LEVOTHYROXINE SODIUM 673 567 2 1
AMLODIPINE BESYLATE 667 570 3 5
LISINOPRIL 597 506 4 4
WARFARIN SODIUM 536 469 5 10
SIMVASTATIN 516 456 6 3
OMEPRAZOLE 485 414 7 6
HYDROCODONE-ACETAMINOPHEN 474 341 S3 8 2
METOPROLOL TARTRATE 424 399 9 9
POTASSIUM CHLORIDE 381 360 10 16
METFORMIN HCL 345 282 11 8
NAMENDA 307 307 12 32
ISOSORBIDE MONONITRATE ER 281 262 13 40
METOPROLOL SUCCINATE 263 249 14 13
DONEPEZIL HCL 247 247 15 24
GABAPENTIN 230 162 16 15
LANTUS 219 195 17 38
ESCITALOPRAM OXALATE 218 176 18 54
POLYETHYLENE GLYCOL 3350 196 170 19 43
ZOLPIDEM TARTRATE 194 166 20 23
GLIMEPIRIDE 162 132 21 34
PROMETHAZINE HCL 160 112 R 22 97
CLOPIDOGREL 153 131 23 29
HYDROCHLOROTHIAZIDE 147 118 24 12
ATENOLOL 145 129 25 17
DIVALPROEX SODIUM 144 135 26 72
TAMSULOSIN HCL 142 133 27 26
ALLOPURINOL 141 125 28 31
DIGOXIN 136 113 29 61
PLAVIX 134 120 30 51
CRESTOR 133 110 31 27
LEXAPRO 126 115 32 181
SERTRALINE HCL 124 106 33 22
LEVOFLOXACIN 112 89 34 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 89 35 33
PRAVASTATIN SODIUM 105 68 36 14
PREDNISONE 104 93 37 36
MIRTAZAPINE 103 100 38 52
NOVOLIN R 103 97 38 185
ATORVASTATIN CALCIUM 99 96 40 11
CARVEDILOL 98 85 41 21
NEXIUM 94 63 42 28
ALBUTEROL SULFATE 91 86 43 136
NITROFURANTOIN MONO-MACRO 91 75 43 174
HYDRALAZINE HCL 88 79 45 78
ROPINIROLE HCL 87 87 46 74
CLONIDINE HCL 86 81 47 60
LEVETIRACETAM 85 68 48 89
IPRATROPIUM BROMIDE 84 80 49 205
CEFTRIAXONE 80 75 50 227
DILTIAZEM 24HR CD 79 72 51 118
PHENYTOIN SODIUM EXTENDED 79 61 51 141
FLUTICASONE PROPIONATE 78 62 53 46
CYMBALTA 77 66 54 35
PAROXETINE HCL 77 64 54 69
KLOR-CON M20 76 76 56 48
AZITHROMYCIN 76 59 56 41
CITALOPRAM HBR 76 60 56 19
ALENDRONATE SODIUM 76 76 56 25
VERAPAMIL ER 76 69 56 119
BUMETANIDE 75 49 61 131
GLIPIZIDE 74 53 62 71
EXELON 72 72 63 109
METOCLOPRAMIDE HCL 69 57 64 121
COMBIVENT 69 58 64 120
ISOSORBIDE DINITRATE 68 68 66 243
CIPROFLOXACIN HCL 68 56 66 62
CLOTRIMAZOLE-BETAMETHASONE 68 60 66 189
RISPERIDONE 66 64 69 67
TRICOR 64 21 70 134
PROAIR HFA 60 53 71 56
BACLOFEN 59 36 72 125
RANITIDINE HCL 59 42 72 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 41 74 95
NAPROXEN 57 55 74 104
CYCLOBENZAPRINE HCL 57 39 R 74 63
LIDODERM 55 53 77 132
AMOXICILLIN 55 41 77 116
THEOPHYLLINE ANHYDROUS 54 51 79 219
SPIRONOLACTONE 53 46 80 57
CEPHALEXIN 52 39 81 70
ENALAPRIL MALEATE 52 30 81 68
SINGULAIR 52 49 81 90
CELEBREX 50 48 84 93
DILTIAZEM ER 50 45 84 153
MELOXICAM 50 35 84 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.